128 related articles for article (PubMed ID: 36178187)
41. Prediction of radiation pneumonitis in lung cancer patients: a systematic review.
Zhang XJ; Sun JG; Sun J; Ming H; Wang XX; Wu L; Chen ZT
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2103-16. PubMed ID: 22842662
[TBL] [Abstract][Full Text] [Related]
42. Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
Onishi H; Marino K; Yamashita H; Terahara A; Onimaru R; Kokubo M; Shioyama Y; Kozuka T; Matsuo Y; Aruga T; Hiraoka M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801323. PubMed ID: 30286697
[TBL] [Abstract][Full Text] [Related]
43. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
[TBL] [Abstract][Full Text] [Related]
44. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
45. Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?
Ledford JG; Addison KJ; Foster MW; Que LG
Am J Respir Cell Mol Biol; 2014 Nov; 51(5):604-14. PubMed ID: 24960334
[TBL] [Abstract][Full Text] [Related]
46. Pneumonitis and fibrosis after breast cancer radiotherapy: occurrence and treatment-related predictors.
Karlsen J; Tandstad T; Sowa P; Salvesen Ø; Stenehjem JS; Lundgren S; Reidunsdatter RJ
Acta Oncol; 2021 Dec; 60(12):1651-1658. PubMed ID: 34618657
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis.
Beketov VD; Lebedeva MV; Mukhin NA; Serova AG; Ponomarev AB; Popova EN; Yanakaeva AS; Solomka VA; Kondrashov AV; Konovalov DV
Ter Arkh; 2018 Apr; 90(3):42-46. PubMed ID: 30701855
[TBL] [Abstract][Full Text] [Related]
48. Risk factors for radiation pneumonitis caused by whole breast irradiation following breast-conserving surgery.
Kubo A; Osaki K; Kawanaka T; Furutani S; Ikushima H; Nishitani H
J Med Invest; 2009 Aug; 56(3-4):99-110. PubMed ID: 19763021
[TBL] [Abstract][Full Text] [Related]
49. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
50. Postmortem serum levels of pulmonary surfactant-associated proteins A and D with regard to the cause of death in medicolegal autopsy.
Quan L; Zhu BL; Ishikawa T; Michiue T; Zhao D; Yoshida C; Chen JH; Wang Q; Komatsu A; Azuma Y; Maeda H
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S301-3. PubMed ID: 19254864
[TBL] [Abstract][Full Text] [Related]
51. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
Taghian AG; Assaad SI; Niemierko A; Floyd SR; Powell SN
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):386-91. PubMed ID: 15890579
[TBL] [Abstract][Full Text] [Related]
52. Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation.
Kharofa J; Gore E
Clin Lung Cancer; 2013 May; 14(3):283-7. PubMed ID: 23291257
[TBL] [Abstract][Full Text] [Related]
53. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Mehta V
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
[TBL] [Abstract][Full Text] [Related]
54. Surfactant Protein-D: A sensitive predictor for efficiency of preoperative pulmonary rehabilitation.
Huang J; Lai Y; Gao K; Wang Y; Du H; Su J; Che G; Zhou X
Int J Surg; 2017 May; 41():136-142. PubMed ID: 28385654
[TBL] [Abstract][Full Text] [Related]
55. [Diffuse lung diseases and biological markers in serum].
Takahashi H; Shiratori M
Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):986-92. PubMed ID: 16846044
[No Abstract] [Full Text] [Related]
56. Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy.
Zeng Q; Tang C; Deng L; Li S; Liu J; Wang S; Shan H
Int J Med Sci; 2020; 17(16):2561-2569. PubMed ID: 33029098
[No Abstract] [Full Text] [Related]
57. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
Müller G; Kiricuta IC; Stiess J; Bohndorf W
Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
[TBL] [Abstract][Full Text] [Related]
58. Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation.
Zhou P; Chen L; Yan D; Huang C; Chen G; Wang Z; Zhong L; Luo W; Chen D; Chun C; Zhang S; Li G
Cancer Med; 2020 May; 9(10):3437-3444. PubMed ID: 32207253
[TBL] [Abstract][Full Text] [Related]
59. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
60. Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
Chen X; Sheikh K; Nakajima E; Lin CT; Lee J; Hu C; Hales RK; Forde PM; Naidoo J; Voong KR
Oncologist; 2021 Oct; 26(10):e1822-e1832. PubMed ID: 34251728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
